Pharmacological [bmod]
Review [inpr]
Selective Estrogen Receptor Modulators [horm, phsu]
Diverse [qlco]
Non [ftcn]
Steroid [strd]
Compound [qlco]
Bind [acty]
Estrogen Receptors [aapp, rcpt]
Estrogen Effects [fndg]
Agonist [phsu]
Tissues [tisu]
Estrogen Effects [fndg]
Antagonist [ortf]
Others [fndg]
Selective Estrogen Receptor Modulators [horm, phsu]
Evaluated [ftcn]
Estrogen [horm, phsu, strd]
Diseases [dsyn]
Including [ftcn]
Past [tmco]
Menopausal osteoporosis [dsyn]
Hormone [horm]
Dependent [qlco]
Cancer [neop]
Cardiovascular disease [dsyn]
Several [qnco]
Compound [qlco]
Exhibit [inpr]
SERM [horm, phsu]
Profile [lbpr]
Currently [tmco]
Available [ftcn]
Clinical [qlco]
Including [ftcn]
Clomifen [orch, phsu]
Tamoxifen [orch, phsu]
Toremifene [orch, phsu]
Raloxifene [orch, phsu]
benzothiophene [orch]
Clomifen [orch, phsu]
Induction [ftcn]
Ovulation [ortf]
Sub-Fertility [dsyn]
Women [popg]
Attempt [evnt]
Pregnancy [orgf]
Tamoxifen [orch, phsu]
Toremifene [orch, phsu]
To [qlco]
TREAT [ftcn]
Breast Cancer [neop]
Tamoxifen [orch, phsu]
effects [qlco]
Bone Mineral Density [clna]
Serum lipids NOS [lbpr]
effects [qlco]
Toremifene [orch, phsu]
Serum lipids NOS [lbpr]
Similar [qlco]
Tamoxifen [orch, phsu]
Compound [qlco]
effects [qlco]
Endometrium [bpoc]
Raloxifene [orch, phsu]
Indicated [fndg]
treatment [ftcn]
Prevention [topp]
Osteoporosis, Post-Menopausal [dsyn]
effects [qlco]
Bone Mineral Density [clna]
Serum lipids NOS [lbpr]
Not [ftcn]
Increase [ftcn]
Risk [qlco]
Endometrial Hyperplasia [dsyn]
Endometrial Cancer [neop]
Recently [tmco]
Raloxifene [orch, phsu]
Show [inpr]
To [qlco]
Incidence [qnco]
Vertebral Fracture [inpo]
Health [idcn]
Women [popg]
Osteoporosis [dsyn]
Same [qlco]
Study [mnob]
Reduced [qlco]
Incidence [qnco]
Breast Cancer [neop]
Observed [ftcn]
Similar [qlco]
Oestrogens [horm, phsu, strd]
Selective Estrogen Receptor Modulators [horm, phsu]
Increase [ftcn]
Incidence [qnco]
Venous Thromboembolism [patf]
Several [qnco]
New [tmco]
Compound [qlco]
Exhibit [inpr]
SERM [horm, phsu]
Profile [lbpr]
Clinical [qlco]
development [phsf]
Including [ftcn]
triphenylethylene [orch, phsu]
droloxifene [orch, phsu]
idoxifene [orch, phsu]
benzothiophene [orch]
Benzopyrans [orch]
Naphthalenes [orch]
